Bad pharma: how drug companies mislead doctors and harm patients
(Book)
Author:
Published:
New York : Faber and Faber, Inc., an affiliate of Farrar, Straus and Giroux, 2013.
Format:
Book
Edition:
First American edition.
Physical Desc:
xvii, 426 pages ; 22 cm
Status:
Description
Argues that doctors are deliberately misinformed by profit-seeking pharmaceutical companies who withhold information about drug efficacy and side effects, explaining pharmaceutical data manipulation and its consequences.
Copies
Location
Call Number
Status
Branford/Blackstone Adult Nonfiction
615.1 GOL
On Shelf
Durham Adult Non-Fiction
615.1072 GOL
On Shelf
East Lyme Public Adult Non-Fiction
615.1072 Goldacre
On Shelf
Essex Adult Nonfiction
615.1 GOL
On Shelf
Ledyard/Bill Nonfiction
615.1072 Gol
On Shelf
North Haven Adult Nonfiction
615.1 Goldacre
On Shelf
Old Saybrook/Acton Adult Non-Fiction
615.107 GOLDACRE
On Shelf
Orange/Case Adult Nonfiction Book
615.1 Goldacre
On Shelf
Woodbridge Adult NF 600-699
615.10724/GOL
On Shelf
More Details
Language:
English
ISBN:
0865478007, 9780865478008
Notes
Bibliography
Includes bibliographical references and index.
Description
Argues that doctors are deliberately misinformed by profit-seeking pharmaceutical companies who withhold information about drug efficacy and side effects, explaining pharmaceutical data manipulation and its consequences.
Reviews from GoodReads
Loading GoodReads Reviews.
Citations
APA Citation (style guide)
Goldacre, B. (2013). Bad pharma: how drug companies mislead doctors and harm patients. First American edition. New York, Faber and Faber, Inc., an affiliate of Farrar, Straus and Giroux.
Chicago / Turabian - Author Date Citation (style guide)Goldacre, Ben. 2013. Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients. New York, Faber and Faber, Inc., an affiliate of Farrar, Straus and Giroux.
Chicago / Turabian - Humanities Citation (style guide)Goldacre, Ben, Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients. New York, Faber and Faber, Inc., an affiliate of Farrar, Straus and Giroux, 2013.
MLA Citation (style guide)Goldacre, Ben. Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients. First American edition. New York, Faber and Faber, Inc., an affiliate of Farrar, Straus and Giroux, 2013.
Note! Citation formats are based on standards as of July 2022. Citations contain only title, author, edition, publisher, and year published. Citations should be used as a guideline and should be double checked for accuracy.
Staff View
Grouped Work ID:
da19d9e1-e828-d419-2ef6-3512ed58d3ca
Record Information
| Last Sierra Extract Time | Apr 19, 2024 03:19:18 PM |
|---|---|
| Last File Modification Time | Apr 19, 2024 03:19:50 PM |
| Last Grouped Work Modification Time | Apr 19, 2024 03:19:24 PM |
MARC Record
| LEADER | 02488cam 2200469 i 4500 | ||
|---|---|---|---|
| 001 | BK0011799954 | ||
| 003 | DLC | ||
| 005 | 20121023144447.0 | ||
| 008 | 121019s2013 nyu b 001 0 eng | ||
| 010 | |a 2012038902 | ||
| 020 | |a 0865478007|c 28.00 | ||
| 020 | |a 9780865478008|c 28.00 | ||
| 040 | |a DLC|b eng|c DLC|e rda|d NjBwBT|d WBR | ||
| 050 | 0 | 0 | |a RM301.27|b .G65 2013 |
| 082 | 0 | 0 | |a 615.1072/4|2 23 |
| 100 | 1 | |a Goldacre, Ben. | |
| 245 | 1 | 0 | |a Bad pharma :|b how drug companies mislead doctors and harm patients /|c Ben Goldacre. |
| 250 | |a First American edition. | ||
| 264 | 1 | |a New York :|b Faber and Faber, Inc., an affiliate of Farrar, Straus and Giroux,|c 2013. | |
| 300 | |a xvii, 426 pages ;|c 22 cm | ||
| 336 | |a text|2 rdacontent | ||
| 337 | |a unmediated|2 rdamedia | ||
| 338 | |a volume|2 rdacarrier | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Intro -- Missing data -- Where do new drugs come from? -- Bad regulators -- Bad trials -- Bigger, simpler trials -- Marketing -- Afterword: better data. | |
| 520 | |a Argues that doctors are deliberately misinformed by profit-seeking pharmaceutical companies who withhold information about drug efficacy and side effects, explaining pharmaceutical data manipulation and its consequences. | ||
| 650 | 0 | |a Drugs|x Testing. | |
| 650 | 0 | |a Drugs|x Testing|x Moral and ethical aspects. | |
| 650 | 0 | |a Clinical trials|x Moral and ethical aspects. | |
| 650 | 0 | |a Pharmaceutical industry|x Moral and ethical aspects. | |
| 650 | 0 | |a Drugs|x Quality control. | |
| 907 | |a .b22448287 | ||
| 945 | |y .i46922842|i 22701698982|l duan|s -|h |u 6|x 0|w 0|v 4|t 2|z 01-29-13|o -|a 615.1072 GOL | ||
| 945 | |y .i46988580|i 31216003464794|l nhan|s -|h |u 8|x 0|w 0|v 4|t 2|z 02-13-13|o -|a 615.1 Goldacre | ||
| 945 | |y .i47131391|i 20602978774 |l elan|s -|h |u 3|x 0|w 0|v 0|t 2|z 03-12-13|o -|a 615.1072 Goldacre | ||
| 945 | |y .i4722065x|i 20802358798|l lban|s -|h |u 5|x 0|w 0|v 1|t 2|z 03-29-13|o -|a 615.1072 Gol | ||
| 945 | |y .i47265437|i 32159001945837|l oran|s -|h |u 9|x 0|w 0|v 1|t 2|z 04-08-13|o -|a 615.1 Goldacre | ||
| 945 | |y .i48095114|i 20702454593|l bran|s -|h |u 19|x 0|w 0|v 9|t 2|z 05-01-13|o -|a 615.1 GOL | ||
| 945 | |y .i48104814|i 33520000356079|l osan|s -|h |u 7|x 0|w 1|v 1|t 2|z 05-02-13|o -|a 615.107 GOLDACRE | ||
| 945 | |y .i48248186|i 21500931084|l exan|s -|h |u 5|x 0|w 0|v 3|t 2|z 05-31-13|o -|a 615.1 GOL | ||
| 945 | |y .i48300998|i 21802229402|l wdan6|s -|h |u 8|x 0|w 0|v 4|t 2|z 06-11-13|o -|a 615.10724/GOL | ||
| 998 | |e -|d a |f eng|a br|a du|a el|a ex|a lb|a nh|a os|a or|a wd | ||
